Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia (COES)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00169065 |
|
Recruitment Status
:
Completed
First Posted
: September 15, 2005
Last Update Posted
: April 7, 2015
|
Sponsor:
Harvard Medical School
Collaborators:
National Institute of Mental Health (NIMH)
Dartmouth-Hitchcock Medical Center
Commonwealth Research Center, Massachusetts
Eli Lilly and Company
Information provided by (Responsible Party):
AlanGreen, National Institute of Mental Health (NIMH)
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | June 2002 |
| Actual Study Completion Date : | June 2002 |